Jagsonpal Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Jagsonpal Pharmaceuticals had annual revenue of 2.69B INR with 28.76% growth. Jagsonpal Pharmaceuticals had revenue of 585.60M in the quarter ending March 31, 2025, with 34.66% growth.

Revenue

2.69B

Revenue Growth

+28.76%

P/S Ratio

5.25

Revenue / Employee

2.62M

Employees

1,025

Market Cap

14.10B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.69B	600.14M	28.76%
Mar 31, 2024	2.09B	-280.12M	-11.83%
Mar 31, 2023	2.37B	191.30M	8.79%
Mar 31, 2022	2.18B	296.38M	15.77%
Mar 31, 2021	1.88B	293.78M	18.53%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Apr 1, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	516.03B
Divi's Laboratories	90.78B
Cipla	271.45B
Mankind Pharma	116.41B
Apollo Hospitals Enterprise	211.46B
Zydus Lifesciences	222.47B
Aurobindo Pharma	309.22B
Alkem Laboratories	127.57B

Revenue Rankings

Jagsonpal Pharmaceuticals News

3 months ago - Jagsonpal Pharmaceuticals shares drop 2.6% after USFDA issues warning letter for manufacturing lapses at API plant - Business Upturn
3 months ago - Jagsonpal Pharmaceuticals acquires Resilient Cosmeceuticals’ India business for Rs 24 crore - Business Upturn
4 months ago - Jagsonpal Pharmaceuticals shares jump nearly 6% on strong Q3 FY25 results - Business Upturn
8 months ago - Jagsonpal Pharmaceuticals block trade: 22 lakh shares exchanged in ₹88 crore deal - Business Upturn

More News